Breast cancer expression of DAP12 is associated with skeletal and liver metastases and poor survival

Clinical Breast Cancer

Volumn 13, Issue 5, 2013, Pages 371-377

  Shabo, Ivan ^a   Olsson, Hans ^a   Stål, Olle ^a   Svanvik, Joar ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Cell fusion; Tissue specific metastasis; Tumor immunology; Tumor microenvironment; Tumor associated macrophages

Indexed keywords

CD163 ANTIGEN; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; TAMOXIFEN;

ARTICLE; BONE METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CELL HOMING; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LUNG METASTASIS; MACROPHAGE; MAJOR CLINICAL STUDY; PARTIAL MASTECTOMY; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SURVIVAL TIME;

CELL FUSION; TISSUE-SPECIFIC METASTASIS; TUMOR IMMUNOLOGY; TUMOR-ASSOCIATED MACROPHAGES; TUMOR MICROENVIRONMENT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BONE NEOPLASMS; BREAST NEOPLASMS; CELL MOVEMENT; FEMALE; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MACROPHAGES; MEMBRANE PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS;

EID: 84883762371     PISSN: 15268209     EISSN: 19380666     Source Type: Journal    
DOI: 10.1016/j.clbc.2013.05.003     Document Type: Article

References (55)

1. M. Alvarez-Dolado, R. Pardal, and J.M. Garcia-Verdugo Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes Nature 425 2003 968 973
2. J.M. Nygren, S. Jovinge, and M. Breitbach Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation Nat Med 10 2004 494 501
3. J.M. Nygren, K. Liuba, and M. Breitbach Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion Nat Cell Biol 10 2008 584 592
4. J. Gao, A. Knutsen, and G. Arbman Clinical and biological significance of angiogenesis and lymphangiogenesis in colorectal cancer Dig Liver Dis 41 2009 116 122
5. C. Liu, Z. Chen, and T. Zhang Multiple tumor types may originate from bone marrow-derived cells Neoplasia 8 2006 716 724
6. A.Z. Rizvi, J.R. Swain, and P.S. Davies Bone marrow-derived cells fuse with normal and transformed intestinal stem cells Proc Natl Acad Sci U S A 103 2006 6321 6325
7. Y. Yilmaz, R. Lazova, and M. Qumsiyeh Donor Y chromosome in renal carcinoma cells of a female BMT recipient: visualization of putative BMT-tumor hybrids by FISH Bone Marrow Transplant 35 2005 1021 1024
8. L.T. Busund, M.K. Killie, and K. Bartnes Spontaneously formed tumorigenic hybrids of Meth A sarcoma cells and macrophages in vivo Int J Cancer 106 2003 153 159
9. L. Larizza, V. Schirrmacher, and E. Pfluger Acquisition of high metastatic capacity after in vitro fusion of a nonmetastatic tumor line with a bone marrow-derived macrophage J Exp Med 160 1984 1579 1584
10. M. Rachkovsky, S. Sodi, and A. Chakraborty Melanoma x macrophage hybrids with enhanced metastatic potential Clin Exp Metastasis 16 1998 299 312
11. A.E. Powell, E.C. Anderson, and P.S. Davies Fusion between intestinal epithelial cells and macrophages in a cancer context results in nuclear reprogramming Cancer Res 71 2011 1497 1505
12. J.M. Pawelek Tumour-cell fusion as a source of myeloid traits in cancer Lancet Oncol 6 2005 988 993
13. M. Lucas, L. Daniel, and E. Tomasello Massive inflammatory syndrome and lymphocytic immunodeficiency in KARAP/DAP12-transgenic mice Eur J Immunol 32 2002 2653 2663
14. J. Paloneva, J. Mandelin, and A. Kiialainen DAP12/TREM2 deficiency results in impaired osteoclast differentiation and osteoporotic features J Exp Med 198 2003 669 675
15. T. Kaifu, J. Nakahara, and M. Inui Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice J Clin Invest 111 2003 323 332
16. A.B. Bakker, R.M. Hoek, and A. Cerwenka DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming Immunity 13 2000 345 353
17. M. Kristiansen, J.H. Graversen, and C. Jacobsen Identification of the haemoglobin scavenger receptor Nature 409 2001 198 201
18. T.T. Nguyen, E.J. Schwartz, and R.B. West Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage Am J Surg Pathol 29 2005 617 624
19. A. Mantovani, S. Sozzani, and M. Locati Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 2002 549 555
20. J. Condeelis, and J.W. Pollard Macrophages: obligate partners for tumor cell migration, invasion, and metastasis Cell 124 2006 263 266
21. J.W. Pollard Tumour-educated macrophages promote tumour progression and metastasis Nat Rev Cancer 4 2004 71 78
22. E.Y. Lin, J.F. Li, and L. Gnatovskiy Macrophages regulate the angiogenic switch in a mouse model of breast cancer Cancer Res 66 2006 11238 11246
23. E.Y. Lin, and J.W. Pollard Tumor-associated macrophages press the angiogenic switch in breast cancer Cancer Res 67 2007 5064 5066
24. A. Sica, T. Schioppa, and A. Mantovani Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy Eur J Cancer 42 2006 717 727
25. Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer. Swedish Breast Cancer Cooperative Group J Natl Cancer Inst 88 1996 1543 1549
26. I. Shabo, O. Stal, and H. Olsson Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival Int J Cancer 123 2008 780 786
27. J.R. Landis, and G.G. Koch The measurement of observer agreement for categorical data Biometrics 33 1977 159 174
28. I. Shabo, H. Olsson, and X.F. Sun Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time Int J Cancer 125 2009 1826 1831
29. A.K. Chakraborty, J. de Freitas Sousa, and E.M. Espreafico Human monocyte x mouse melanoma fusion hybrids express human gene Gene 275 2001 103 106
30. A.K. Chakraborty, N. Kolesnikova, and F. Sousa Jde Expression of c-Met proto-oncogene in metastatic macrophage x melanoma fusion hybrids: implication of its possible role in MSH-induced motility Oncol Res 14 2003 163 174
31. A.K. Chakraborty, and J. Pawelek Beta1,6-branched oligosaccharides regulate melanin content and motility in macrophage-melanoma fusion hybrids Melanoma Res 17 2007 9 16
32. A.K. Chakraborty, J. Pawelek, and Y. Ikeda Fusion hybrids with macrophage and melanoma cells up-regulate N-acetylglucosaminyltransferase V, beta1-6 branching, and metastasis Cell Growth Differ 12 2001 623 630
33. A.F. Chambers, A.C. Groom, and I.C. MacDonald Dissemination and growth of cancer cells in metastatic sites Nat Rev Cancer 2 2002 563 572
34. I.J. Fidler The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited Nat Rev Cancer 3 2003 453 458
35. J.M. Pawelek Cancer-cell fusion with migratory bone-marrow-derived cells as an explanation for metastasis: new therapeutic paradigms Future Oncol 4 2008 449 452
36. J.M. Pawelek, and A.K. Chakraborty Fusion of tumour cells with bone marrow-derived cells: a unifying explanation for metastasis Nat Rev Cancer 8 2008 377 386
37. L.T. Busund, M.K. Killie, K. Bartnes, and R. Seljelid Spontaneously formed tumorigenic hybrids of Meth A sarcoma and macrophages grow faster and are better vascularized than the parental tumor Int J Cancer 100 2002 407 413
38. L. Helming, and S. Gordon The molecular basis of macrophage fusion Immunobiology 212 2007 785 793
39. L. Helming, E. Tomasello, and T.R. Kyriakides Essential role of DAP12 signaling in macrophage programming into a fusion-competent state Sci Signal 1 2008 ra11
40. A.S. Tessarz, and A. Cerwenka The TREM-1/DAP12 pathway Immunol Lett 116 2008 111 116
41. M.B. Humphrey, M.R. Daws, and S.C. Spusta TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function J Bone Miner Res 21 2006 237 245
42. L.A. Kingsley, P.G. Fournier, and J.M. Chirgwin Molecular biology of bone metastasis Mol Cancer Ther 6 2007 2609 2617
43. W. Kozlow, and T.A. Guise Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy J Mammary Gland Biol Neoplasia 10 2005 169 180
44. S.J. Bakewell, P. Nestor, and S. Prasad Platelet and osteoclast beta3 integrins are critical for bone metastasis Proc Natl Acad Sci U S A 100 2003 14205 14210
45. K.P. McHugh, K. Hodivala-Dilke, and M.H. Zheng Mice lacking beta3 integrins are osteosclerotic because of dysfunctional osteoclasts J Clin Invest 105 2000 433 440
46. G.P. Gupta, and J. Massague Cancer metastasis: building a framework Cell 127 2006 679 695
47. M. Bendre, D. Gaddy, and R.W. Nicholas Breast cancer metastasis to bone: it is not all about PTHrP Clin Orthop Relat Res 415 Suppl 2003 S39 S45
48. T. Kelly, L.J. Suva, and Y. Huang Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases Cancer Res 65 2005 5778 5784
49. S. Braun, K. Pantel, and P. Muller Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer N Engl J Med 342 2000 525 533
50. J.T. Kaifi, E.F. Yekebas, and P. Schurr Tumor-cell homing to lymph nodes and bone marrow and CXCR4 expression in esophageal cancer J Natl Cancer Inst 97 2005 1840 1847
51. S. Thorban, J.D. Roder, and H. Nekarda Immunocytochemical detection of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma J Natl Cancer Inst 88 1996 1222 1227
52. K.W. Jauch, M.M. Heiss, and U. Gruetzner Prognostic significance of bone marrow micrometastases in patients with gastric cancer J Clin Oncol 14 1996 1810 1817
53. J.T. Kaifi, U. Reichelt, and A. Quaas L1 is associated with micrometastatic spread and poor outcome in colorectal cancer Mod Pathol 20 2007 1183 1190
54. S. Morony, C. Capparelli, and I. Sarosi Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis Cancer Res 61 2001 4432 4436
55. C. Capparelli, P.J. Kostenuik, and S. Morony Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy Cancer Res 60 2000 783 787